Back to Search
MEGHNA TRIVEDI, MD
MD
Medical Oncology Physician
NPI: 1689993537IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
MT197590(PA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
269039(NY)
Education
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
Class of 2010
Research & Publications (20)
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.
PMID 17513980·J Am Acad Child Adolesc Psychiatry·2007
8-other
Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression.
PMID 19607755·Psychol Med·2010
2-rct
Do atypical features affect outcome in depressed outpatients treated with citalopram?
PMID 19341509·Int J Neuropsychopharmacol·2010
3-trial
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
PMID 19460188·Psychol Med·2010
4-observational
Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
PMID 19493369·Psychol Med·2010
8-other
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
PMID 19382183·Depress Anxiety·2009
3-trial
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
PMID 19434623·Depress Anxiety·2009
8-other
Characterization of a robust enzymatic assay for inhibitors of 2-oxoglutarate-dependent hydroxylases.
PMID 19498081·J Biomol Screen·2009
8-other
Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms.
PMID 19589048·Expert Rev Neurother·2009
6-review
Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
PMID 19407731·CNS Spectr·2009
4-observational
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
PMID 19339358·Am J Psychiatry·2009
3-trial
Optimal use of G-CSF administration after hematopoietic SCT.
PMID 19363527·Bone Marrow Transplant·2009
6-review
A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder.
PMID 19507161·Int J Methods Psychiatr Res·2009
8-other
Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention.
PMID 19339845·J Psychiatr Pract·2009
8-other
Income and attrition in the treatment of depression: a STAR*D report.
PMID 19582825·Depress Anxiety·2009
3-trial
Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning.
PMID 19318972·Int Clin Psychopharmacol·2009
8-other
The role of thiols and disulfides on protein stability.
PMID 19538140·Curr Protein Pept Sci·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 177 FORT WASHINGTON AVE
NEW YORK, NY 10032 - Phone
- (212) 305-8923
Quick Facts
- NPI
- 1689993537
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile